1. Home
  2. TFSL vs KYMR Comparison

TFSL vs KYMR Comparison

Compare TFSL & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TFSL
  • KYMR
  • Stock Information
  • Founded
  • TFSL 1938
  • KYMR 2015
  • Country
  • TFSL United States
  • KYMR United States
  • Employees
  • TFSL N/A
  • KYMR N/A
  • Industry
  • TFSL Savings Institutions
  • KYMR Medicinal Chemicals and Botanical Products
  • Sector
  • TFSL Finance
  • KYMR Health Care
  • Exchange
  • TFSL Nasdaq
  • KYMR Nasdaq
  • Market Cap
  • TFSL 3.5B
  • KYMR 3.0B
  • IPO Year
  • TFSL 2007
  • KYMR 2020
  • Fundamental
  • Price
  • TFSL $14.41
  • KYMR $43.32
  • Analyst Decision
  • TFSL Hold
  • KYMR Buy
  • Analyst Count
  • TFSL 2
  • KYMR 14
  • Target Price
  • TFSL $14.00
  • KYMR $52.14
  • AVG Volume (30 Days)
  • TFSL 303.9K
  • KYMR 405.5K
  • Earning Date
  • TFSL 10-30-2024
  • KYMR 10-31-2024
  • Dividend Yield
  • TFSL 8.02%
  • KYMR N/A
  • EPS Growth
  • TFSL 7.69
  • KYMR N/A
  • EPS
  • TFSL 0.28
  • KYMR N/A
  • Revenue
  • TFSL $304,660,000.00
  • KYMR $87,563,000.00
  • Revenue This Year
  • TFSL N/A
  • KYMR N/A
  • Revenue Next Year
  • TFSL $6.83
  • KYMR $21.47
  • P/E Ratio
  • TFSL $50.39
  • KYMR N/A
  • Revenue Growth
  • TFSL N/A
  • KYMR 86.92
  • 52 Week Low
  • TFSL $11.70
  • KYMR $18.89
  • 52 Week High
  • TFSL $15.25
  • KYMR $53.27
  • Technical
  • Relative Strength Index (RSI)
  • TFSL 60.60
  • KYMR 40.51
  • Support Level
  • TFSL $13.66
  • KYMR $41.12
  • Resistance Level
  • TFSL $14.53
  • KYMR $53.23
  • Average True Range (ATR)
  • TFSL 0.32
  • KYMR 2.41
  • MACD
  • TFSL 0.03
  • KYMR -0.72
  • Stochastic Oscillator
  • TFSL 81.15
  • KYMR 19.16

About TFSL TFS Financial Corporation

TFS Financial Corp is the holding company for the Third Federal Savings and Loan Association of Cleveland. The company's ownership in the savings and loan association is its primary business activity. The association's principal business consists of originating and servicing residential real estate mortgage loans and attracting retail savings deposits. It does so by offering products with competitive rates and yields. The company also operates Third Capital, a wholly owned subsidiary that serves as a holding company or as an investor in vehicles such as private equity funds. Third Capital has interests in lease transactions of commercial buildings, title agencies providing escrow and settlement services, and reinsurance of private mortgage insurance on residential loans.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.

Share on Social Networks: